KeyBanc analyst Leo Mariani initiates coverage on Black Stone Minerals (NYSE:BSM) with a Sector Weight rating.
Oppenheimer Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $30
Oppenheimer analyst Jay Olson initiates coverage on Revolution Medicines (NASDAQ:RVMD) with a Outperform rating and announces Price Target of $30.